Your browser doesn't support javascript.
loading
Clinical characteristics of macrophage activation syndrome in adult-onset Still's disease.
Gao, Qi; Yuan, Yi; Wang, Yueqi; Jiang, Jing; Ye, Zhuang; Liu, Tao; Jiang, Zhenyu; Zhao, Ling.
Affiliation
  • Gao Q; Department of Rheumatology, the First Hospital of Jilin University, Changchun, Jilin, China.
  • Yuan Y; Department of Rheumatology, the First Hospital of Jilin University, Changchun, Jilin, China.
  • Wang Y; Division of Clinical Research, The First Hospital of Jilin University, Changchun, Jilin, China.
  • Jiang J; Division of Clinical Research, The First Hospital of Jilin University, Changchun, Jilin, China.
  • Ye Z; Department of Rheumatology, the First Hospital of Jilin University, Changchun, Jilin, China.
  • Liu T; Department of Rheumatology, the First Hospital of Jilin University, Changchun, Jilin, China.
  • Jiang Z; Department of Rheumatology, the First Hospital of Jilin University, Changchun, Jilin, China. jiangzhenyu2012@163.com.
  • Zhao L; Department of Rheumatology, the First Hospital of Jilin University, Changchun, Jilin, China. zhaoling52@163.com.
Clin Exp Rheumatol ; 39 Suppl 132(5): 59-66, 2021.
Article in En | MEDLINE | ID: mdl-34251315
ABSTRACT

OBJECTIVES:

Macrophage activation syndrome (MAS) is considered the most severe complication of adult-onset Still's disease (AOSD). This retrospective observational study was conducted to explore the clinical characteristics of AOSD-MAS patients, the risk factors for MAS in AOSD and prognostic factors in AOSD. Early changes in the clinical characteristics of AOSD-MAS were also studied.

METHODS:

111 hospitalised AOSD patients were included in this retrospective analysis and analysed for the features of AOSD-MAS, selecting independent risk factors associated with MAS and the correlations between clinical characteristics and patient survival.

RESULTS:

Nine subjects (8.1%) developed MAS. AOSD-MAS patients had a higher incidence of jaundice (33.3% vs. 2.9%, p=0.007) and aspartate aminotransferase (AST) greater than 5-fold (33.3% vs. 2.9%, p=0.007). Jaundice was associated with an increased risk of MAS (OR=16.50, 95% CI 2.73-99.82, p=0.002). The AOSD-MAS group had a higher mortality rate (55.6% vs. 8.0%, p=0.001). MAS (HR=11.22, 95% CI 3.46-36.38, p<0.001), and white blood cell (WBC) greater than 20 109/L (HR=5.80, 95% CI 1.09-30.92, p=0.040) were independent prognostic factors for death in AOSD patients. In the AOSD-MAS group, transaminase, triglycerides (TGs) and serum ferritin (SF) were elevated in the early disease stage, sometimes earlier than changes in blood cells in MAS.

CONCLUSIONS:

MAS occurrence significantly reduced the survival rate of patients with AOSD. The presence of jaundice was associated with MAS occurrence. MAS and a WBC count >20 109/L were associated with a high risk of AOSD-related death. AOSD should alert the possibility of MAS when elevated transaminase, TGs and SF cannot be explained.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Still&apos;s Disease, Adult-Onset / Macrophage Activation Syndrome Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Exp Rheumatol Year: 2021 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Still&apos;s Disease, Adult-Onset / Macrophage Activation Syndrome Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Exp Rheumatol Year: 2021 Type: Article Affiliation country: China